Legal Analysis

With Project 2025 underway, what is the bio-based polymer research and development trajectory?

Canada regulators excluded fluoropolymers from PFAS classification based on factors related to environmental behavior and exposure risks.

A new one-step, room-temperature extraction method enables accurate, non-targeted quantification of Non-Intentionally Added Substances (NIAS) in Polystyrene.

The UK’s Extended Producer Responsibility scheme reshapes packaging design and recycling. Businesses now face new rules, fees, and sustainability standards.

The world is bracing to adapt as the new administration reveals its hand. Changes in trade agreements will likely reshape supply chains.

The FDA proposes at-a-glance nutrition labels for the front of packaged foods, offering the U.S. an opportunity to learn valuable lessons from LATAM’s experience.

Conor Carlin, SPE President, discusses SPE’s role in the Global Plastic Pollution Treaty, emphasizing its position as an impartial, technical organization capable of contributing to the treaty’s inherent challenges.

What are leachables in medical plastics? Why are they relevant and what is the issue? Diving into this topic impacts us all.

Plastics such as PTFE flood the medical industry daily. Examining PTFE’s past and present guides us towards its sustainable future.

PFAS regulation. Should they stay, or should they go? Legislative insights offer answers to common questions.